Avid Bioservices Inc (CDMO)

[goodplenty100]

He is not a MD

His Bio


Robert Schwartz
ABOUT
Dr. Schwartz is a 30-year veteran of the Pharmaceutical Industry most recently in the role of Executive Director, Strategic Transactions for Bristol-Myers Squibb Company where he has more than a dozen completed transactions to his credit. He speaks frequently on the Biotech-Big Pharma dynamics and evolving research and treatment paradigms in oncology and is perhaps best known for predicting FDA’s rejection of Dendreon’s Provenge vaccine in 2007 (San Francisco Chronicle, March 30, 2007). Provenge ultimately won FDA approval in April, 2010.

Dr. Schwartz founded RHS Advisors, LLC, a life-sciences consulting firm, in July 2010.
SNAPSHOT

Description: Company executive. Trading frequency: Weekly
Interests: Options, Stocks - long, Stocks - short, Tech stocks